


Journal of International Oncology››2025,Vol. 52››Issue (8): 517-522.doi:10.3760/cma.j.cn371439-20240528-00087
• Original Article •Previous ArticlesNext Articles
Huang Jinfa1(
), Zheng Lianqiu1, Wu Jinpiao2, Liu Deting1, Chen Huiling2
Received:2024-05-28Revised:2025-05-20Online:2025-08-08Published:2025-09-15Contact:Huang Jinfa E-mail:57203010@qq.comSupported by:
Huang Jinfa, Zheng Lianqiu, Wu Jinpiao, Liu Deting, Chen Huiling. Prediction model for post-TACE infection risk in elderly patients with liver cancer[J]. Journal of International Oncology, 2025, 52(8): 517-522.
"
| 临床资料 | 感染组 (n=18) |
非感染组 (n=132) |
χ2/t值 | P值 |
|---|---|---|---|---|
| 性别 | ||||
| 男 | 13(72.22) | 105(79.55) | 0.16 | 0.686 |
| 女 | 5(27.78) | 27(20.45) | ||
| 年龄(岁) | ||||
| ≥75 | 8(44.44) | 53(40.15) | 0.12 | 0.728 |
| <75 | 10(55.56) | 79(59.85) | ||
| 体质量指数(kg/m2) | 21.36±0.57 | 21.66±0.94 | 1.32 | 0.189 |
| 病灶最大径(cm) | 5.46±1.04 | 5.41±1.16 | 0.17 | 0.863 |
| 病灶数目 | ||||
| 单发 | 14(77.78) | 116(87.88) | 0.66 | 0.416 |
| 多发 | 4(22.22) | 16(12.12) | ||
| TNM分期 | ||||
| Ⅲ期 | 9(50.00) | 75(56.82) | 0.30 | 0.585 |
| Ⅳ期 | 9(50.00) | 57(43.18) | ||
| 分化程度 | ||||
| 高中分化 | 15(83.33) | 110(83.33) | <0.01 | >0.999 |
| 低分化 | 3(16.67) | 22(16.67) | ||
| 病灶破裂出血 | ||||
| 是 | 6(33.33) | 13(9.85) | 5.92 | 0.015 |
| 否 | 12(66.67) | 119(90.15) | ||
| 腹腔积液 | ||||
| 是 | 11(61.11) | 40(30.30) | 6.70 | 0.010 |
| 否 | 7(38.89) | 92(69.70) | ||
| 皮肤或黏膜破损 | ||||
| 是 | 6(33.33) | 12(9.09) | 6.67 | 0.010 |
| 否 | 12(66.67) | 120(90.91) | ||
| PCT(μg/L) | 1.17±0.32 | 0.91±0.14 | 4.13 | <0.001 |
| MFG-E8(pg/ml) | 194.29±45.85 | 158.76±28.63 | 4.55 | <0.001 |
| CXCL9(pg/ml) | 948.49±52.38 | 886.05±50.07 | 4.94 | <0.001 |
| [1] | Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022[J].J Natl Cancer Cent,2024,4(1):47-53. DOI:10.1016/j.jncc.2024.01.006. |
| [2] | Shao Z, Liu X, Peng C, et al. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review[J].World J Surg Oncol,2021,19(1): 293. DOI:10.1186/s12957-021-02401-4. |
| [3] | Wu J, Wu J, Li S, et al. Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a treatment with Chinese characteristics[J].Biosci Trends,2024,18(1): 42-48. DOI:10.5582/bst.2023.01326. pmid:38325823 |
| [4] | Zeng JT, Wang Y, Wang Y, et al. Elevated procalcitonin levels in the absence of infection in procalcitonin-secretin hepatocellular carcinoma: a case report[J].World J Clin Cases,2022,10(29): 10811-10816. DOI:10.12998/wjcc.v10.i29.10811. |
| [5] | Ko DS, Kim SH, Park JY, et al. Milk fat globule-EGF factor 8 contributes to progression of hepatocellular carcinoma[J].Cancers (Basel),2020,12(2): 403. DOI:10.3390/cancers12020403. |
| [6] | Marcovecchio PM, Thomas G, Salek-Ardakani S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer[J].J Immunother Cancer,2021,9(2): e002045. DOI:10.1136/jitc-2020-002045. |
| [7] | 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J].中国实用外科杂志,2020,40(2): 121-138. DOI:10.19538/j.cjps.issn1005-2208.2020.02.01. |
| [8] | Liu H, Yan Y, Chen R, et al. Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma[J].Cancer Cell Int,2020,20: 140. DOI:10.1186/s12935-020-01216-9. pmid:32368186 |
| [9] | 中华人民共和国卫生部. 医院感染诊断标准(试行)[J].现代实用医学,2003,15(7): 460-465. DOI:10.3969/j.issn.1671-0800.2003.07.045. |
| [10] | Oh CH. Transcatheter arterial chemoembolization-induced bile duct necrosis with hemobilia in hepatocellular carcinoma: endoscopic visualization and repair[J].Endoscopy,2021,53(7): E265-E266. DOI:10.1055/a-1260-2874.Epub. |
| [11] | 刘松, 于广计, 王庆东. DEBIRI-TACE联合瑞戈非尼三线以上治疗结直肠癌肝转移的疗效及影响因素分析[J].国际肿瘤学杂志,2022,49(7): 400-407. DOI:10.3760/cma.j.cn371439-20220318-00077. |
| [12] | Nakagomi R, Tateishi R, Mikami S, et al. Infectious complications related to radiofrequency ablation of liver tumors: the role of antibio-tics[J].PLoS One,2021,16(11): e0259641. DOI:10.1371/journal.pone.0259641. |
| [13] | Liu KC, Lv WF, Lu D, et al. Initial experience of drug-eluting bead-transcatheter arterial chemoembolization after lipiodol-based transcatheter arterial chemoembolization failure for patients with advanced hepatocellular carcinoma[J].Cancer Manag Res,2021,13: 7973-7980. DOI:10.2147/CMAR.S332571. |
| [14] | Das U, Anandhi A, Sureshkumar S, et al. Procalcitonin and C-reactive protein as an early predictor of infection in elective gastrointestinal cancer surgery—a prospective observational study[J].J Gastrointest Cancer,2022,53(3): 605-613. DOI:10.1007/s12029-021-00661-7. |
| [15] | Li X, Zhang Y, Wang X, et al. Predicting infectious complications after percutaneous thermal ablation of liver malignancies: a 12-year single-center experience[J].Radiology,2023,308(2): e223091. DOI:10.1148/radiol.223091. |
| [16] | Wymer KM, Sharma V, Manka M, et al. A serum C-reactive protein and procalcitonin-based risk score to predict urinary infection in patients with obstructive urolithiasis undergoing decompression[J].J Endourol,2021,35(3): 369-375. DOI:10.1089/end.2020.0163. |
| [17] | 饶亚华, 崔天盆. 乳脂肪球表皮生长因子8与乳腺癌相关性研究进展[J].微循环学杂志,2021,31(2): 66-69. DOI:10.3969/j.issn.1005-1740.2021.02.014. |
| [18] | Wu J, Yang H, Cheng J, et al. Knockdown of milk-fat globule EGF factor-8 suppresses glioma progression in GL261 glioma cells by repressing microglial M2 polarization[J].J Cell Physiol,2020,235(11): 8679-8690. DOI:10.1002/jcp.29712. pmid:32324268 |
| [19] | Liang YK, Deng ZK, Chen MT, et al. CXCL9 is a potential biomarker of immune infiltration associated with favorable prognosis in ER-negative breast cancer[J].Front Oncol,2021,11: 710286. DOI:10.3389/fonc.2021.710286. |
| [20] | Cheng CC, Chang YF, Ho AS, et al. Irradiation mediates IFNα and CXCL9 expression in non-small cell lung cancer to stimulate CD8+T cells activity and migration toward tumors[J].Biomedicines,2021,9(10): 1349. DOI:10.3390/biomedicines9101349. |
| [21] | 孙丽娜, 李小艳, 宫婷, 等. 原发性肝癌TACE介入术后感染病原菌及其血清miR-200a、miR-221、IL-8、CRP 的预测价值[J].中华医院感染学杂志,2024,34(13): 2002-2006. DOI:10.11816/cn.ni.2024-231849. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||